Report cover image

Opioid Use Disorder Market , By Drug Type (Buprenorphine, Methadone, Naltrexone, and Others), By Route of Administration (Oral and Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North A

Publisher Coherent Market Insights
Published Mar 25, 2025
Length 198 Pages
SKU # CMI20008048

Description

Opioids, used medically for pain relief, have analgesic and central nervous system depressant effects as well as the potential to cause euphoria. Opioid use disorder (OUD) can involve misuse of prescribed opioid medications, use of diverted opioid medications, or use of illicitly obtained heroin. OUD is typically a chronic, relapsing illness, associated with significantly increased rates of morbidity and mortality. In patients with OUD who have achieved abstinence through medically supervised withdrawal or by other means, maintenance treatment aims to prevent relapse. Options for long-term maintenance treatment include an opioid agonist (i.e., methadone or buprenorphine), an opioid antagonist (naltrexone), or non-medication, abstinence-based treatment.

Market Dynamics

Increasing incidences of pain associated with chronic diseases such as cancer, rising cases of opioid addiction, and increasing adoption of inorganic growth strategies by key players in order to expand their product portfolio in the global opioid use disorder market. The general population nowadays suffers from a wide range of chronic and severe health conditions, such as pain arising from injuries or cancer. They often result in chronic pain and in such cases, patients are given painkillers, especially opioids. While they help in lowering pain, they can cause addiction among patients. The abrupt discontinuation or higher dependency on these drugs leads to withdrawal symptoms. This further increases the chances of fatal consequences, such as deaths.

For instance, The American Psychiatric Association (APA), stated that approximately 72,000 Americans died due to opioid overdose in 2017. These factors are likely to drive the opioid use disorder market growth in the near future.

Key features of the study:
  • This report provides in-depth analysis of the global opioid use disorder market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global opioid use disorder market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Indivior PLC, Alkermes, Orexo AB, Titan Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, BioDelivery Sciences International Inc., Viatris Inc., Pfizer, Inc., Hikma Pharmaceuticals PLC, and Camurus
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global opioid use disorder market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global opioid use disorder market
Detailed Segmentation:
  • Global Opioid Use Disorder Market, By Drug Type:
  • Buprenorphine
  • Methadone
  • Naltrexone
  • Others
  • Global Opioid Use Disorder Market, By Route of Administration:
  • Oral
  • Parenteral
  • Global Opioid Use Disorder Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Global Opioid Use Disorder Market, By Region:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
  • Company Profiles
  • Indivior PLC
  • Alkermes
  • Orexo AB
  • Titan Pharmaceuticals, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Mallinckrodt Pharmaceuticals
  • BioDelivery Sciences International Inc.
  • Viatris Inc.
  • Pfizer, Inc.
  • Hikma Pharmaceuticals PLC
  • Camurus

Table of Contents

198 Pages
1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Drug Type
Market Snippet, By Route of Administration
Market Snippet, By Distribution Channel
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Opportunities
Recent Test Launches
Product Launches/Approvals
Mergers, Acquisitions, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis
PORTER’s Analysis
4. Global Opioid Use Disorder Market, – COVID-19 Impact Analysis
Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand
5. Global Opioid Use Disorder Market, By Drug Type, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021–2032
Segment Trends
Buprenorphine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Bn)
Methadone
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Bn)
Naltrexone
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Bn)
6. Global Opioid Use Disorder Market, By Route of Administration, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021–2032
Segment Trends
Oral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Bn)
Parenteral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Bn)
7. Global Opioid Use Disorder Market, By Distribution Channel, 2020 – 2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021–2032
Segment Trends
8. Hospitals Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Bn)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Bn)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Bn)
9. Global Opioid Use Disorder Market, By Region, 2020 – 2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021–2032
Segment Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 –2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 –2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020–2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020–2032, (US$ Bn)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 –2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 –2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020–2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020–2032, (US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 –2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 –2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020–2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020–2032, (US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 –2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 –2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020–2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020–2032, (US$ Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 –2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 –2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020–2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020–2032, (US$ Bn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 –2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 –2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020–2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020–2032, (US$ Bn)
North Africa
Central Africa
South Africa
10. Competitive Landscape
Company Profiles
Indivior PLC
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Alkermes
Orexo AB
Titan Pharmaceuticals, Inc.
Teva Pharmaceutical Industries Ltd.
Mallinckrodt Pharmaceuticals
BioDelivery Sciences International Inc.
Viatris Inc.
Hikma Pharmaceuticals PLC
Camurus AB
Sun Pharmaceutical Industries Ltd.
Amneal Pharmaceuticals LLC.
Purdue Pharma LP
Alvogen
Faran Shimi Pharmaceutical
Novartis AG
Emplicure AB
MODASA Pharmaceuticals Pvt. Ltd.
Analysts’ Views
11. Section
References
Research Methodology
About us and Sales Contact
*Browse 35 market data tables and 31 figures on “Global Opioid Use Disorder Market,” – Global forecast to 2032

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us